2m 2m 2m 2m 2m 2m 2m
LARIMAR THERAP (LRMR)
NASDAQ
$3.24-$0.06 (-1.82%)
Price as of Jun 03, 2026 7:28 PM EDT- $361.5MMarket Cap
- 36.93%1-Year Change
- BiotechnologyIndustry
LARIMAR THERAP (LRMR)
$3.24-$0.06 (-1.82%)
LRMR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.30 | ||
Change | -$0.21 (-5.98%) | ||
Open | $3.47 | ||
High | $3.48 | ||
Low | $3.30 | ||
Previous Close | $3.51 | ||
Volume | 1,827,147 | ||
30-Day Average Volume | 1,817,549 | ||
1-Week Change | -4.90% | ||
1-Month Change | -16.24% | ||
1-Year Change | 36.93% | ||
3-Year Change | -13.16% | ||
5-Year Change | -59.76% | ||
Fundamentals | |||
Shares Outstanding | 103.9M | ||
Total Assets | $208.5M | ||
Market Cap | $361.5M | ||
Enterprise Value | $183.6M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$29.6M | ||
Free Cash Flow | -$44.7M | ||
EBIT | -$29.6M | ||
EBITDA | -$29.5M | ||
Net Working Capital | $157.2M | ||
EPS | -$0.31 | ||
Enterprise Value/EBITDA | -6 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -11 | ||
PEG | -0 | ||
Price/Free Cash Flow | -8 | ||
Price/Operating Cash Flow | -8 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue